Early Cardiac Manifestations as the Initial Presentation of Duchenne Muscular Dystrophy in Infancy. [PDF]
Shatarat F +3 more
europepmc +1 more source
YAP Acts as a Negative Regulator of Mini Utrophin-Based Gene Therapy for Duchenne Muscular Dystrophy in Mdx Mice. [PDF]
Li Z, Song Y.
europepmc +1 more source
Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy. [PDF]
Yip CY +4 more
europepmc +1 more source
Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy. [PDF]
Aminzadeh MA +15 more
europepmc +1 more source
Management of Duchenne Muscular Dystrophy in Clinical Practice: A Survey-Based Study in Spain. [PDF]
Ortez C +7 more
europepmc +1 more source
Successful In Vitro Modification of the <i>Dmd</i> Gene Using Prime Editing. [PDF]
Siddika A +3 more
europepmc +1 more source
Duchenne Muscular Dystrophy: Contemporary Therapeutic Options and Real-World Challenges in Treatment Selection. [PDF]
Pesco MT +5 more
europepmc +1 more source
Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial. [PDF]
Clemens PR +11 more
europepmc +1 more source
An Assessment of Paediatricians' Knowledge and Perspectives of Duchenne Muscular Dystrophy in Oman. [PDF]
Al Jabri Z +4 more
europepmc +1 more source
Physical Activity and Quality of Life Among Caregivers of Children with Duchenne Muscular Dystrophy. [PDF]
Yiğit S +5 more
europepmc +1 more source

